Patent Assignment
Reel/Frame 036461/0825
Release of Security Interest
Recorded: 2015-08-31
Pages: 4
Assignor
MACQUARIE US TRADING LLC
Executed: 2015-08-28
Assignee
KADMON PHARMACEUTICALS, LLC
119 COMMONWEALTH DRIVE, WARRENDALE, PENNSYLVANIA, 15086
Covered Properties
(5)
Once Daily Treatment of Hepatitis C with Ribavirin and Taribavirin
PCT:
PCT/US2013/024263 ↗
Process for Producing Wet Ribavirin Pellets
Composition Containing Ribavirin and Use Thereof
Large Dose Ribavirin Formulations
Once Daily Treatment of Hepatitis C with Ribavirin and Taribavirin
Application:
13/988,256 →
Publication:
US 2014/0363396
Related Assignments
(10)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Jun 25, 2013
From: KADMON PHARMACEUTICALS, LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 030678/0514 →
Security Agreement
Jun 25, 2013
From: KADMON PHARMACEUTICALS, LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 030678/0620 →
Assignment of Assignor's Interest
Jul 29, 2013
From: WAKSAL, SAMUEL
To: KADMON PHARMACEUTICALS, LLC
Reel/Frame 030896/0458 →
Assignment of Assignor's Interest
Oct 18, 2013
From: ABBVIE BAHAMAS LTD.
To: ABBVIE INC.
Reel/Frame 031432/0447 →
Assignment of Assignor's Interest
Oct 18, 2013
From: KADMON PHARMACEUTICALS, LLC
To: ABBVIE BAHAMAS LTD.
Reel/Frame 031432/0202 →
Security Interest
Aug 31, 2015
From: KADMON PHARMACEUTICALS, LLC
To: PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP
Reel/Frame 036460/0811 →
Security Interest
Sep 2, 2015
From: KADMON PHARMACEUTICALS, LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 036478/0611 →
Change of Name
Feb 3, 2016
From: THREE RIVERS PHARMACEUTICALS, LLC
To: KADMON PHARMACEUTICALS, LLC
Reel/Frame 037690/0466 →
Termination of Patent and Trademark Security Agreement
Nov 25, 2019
From: PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP
To: KADMON PHARMACEUTICALS, LLC
Reel/Frame 051106/0789 →
Assignment of Assignor's Interest
Jul 26, 2022
From: KADMON PHARMACEUTICALS, LLC
To: CHARTWELL PHARMACEUTICALS LLC
Reel/Frame 060622/0317 →